Annual report pursuant to Section 13 and 15(d)

Discontinued Operations (Tables)

v2.4.0.8
Discontinued Operations (Tables)
 12 Months Ended
Dec. 31, 2013
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]
A rollforward of the liabilities recognized in the consolidated balance sheet as of December 31, 2013 and December 31, 2012 is as follows: 
Accrued liability as of January 1, 2012
$
1,120

Add: Costs incurred, excluding non-cash charges
—

Less: Cash payments
(1,115
)
Accrued liability as of December 31, 2012 (1)
$
5

Add: Costs incurred, excluding non-cash charges
—

Less: Cash payments
(5
)
Accrued liability as of December 31, 2013
$
—


(1)
Accrued liability at December 31, 2012 consists of Pharmakon employee severance costs.
The major classes of assets and liabilities included in the consolidated balance sheets for Pharmakon and TVG as of December 31, 2013 and December 31, 2012 are as follows:

 
December 31,
 
2013
 
2012
Current assets
$
—

 
$
14

Non-current assets
150

 
150

Total assets
$
150

 
$
164

Current liabilities
$
405

 
$
368

Non-current liabilities
619

 
1,006

Total liabilities
$
1,024

 
$
1,374

The table below presents the significant components of Pharmakon's and TVG’s results included in Loss from Discontinued Operations, Net of Tax in the consolidated statements of comprehensive loss for the years ended December 31, 2013 and 2012.

 
For the Years Ended December 31,
 
2013
 
2012
Revenue, net
$
—

 
$
—

 
 
 
 
Loss from discontinued operations, before income tax
(44
)
 
(51
)
Income tax expense
5

 
8

Loss from discontinued operations, net of tax
$
(49
)
 
$
(59
)